Effect of prior foot shock stress and Δ9-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats
- 803 Downloads
Cannabis is commonly used by humans to relieve stress.
Objectives and methods
Here, we evaluate the potential of intraperitoneally (i.p.) administered Δ9-tetrahydrocannabiol (THC) and cannabidiolic acid (CBDA, the precursor of cannabidiol [CBD]) to produce dose-dependent effects on anxiety-like responding in the light-dark (LD) emergence test of anxiety-like responding in rats, when administered acutely or chronically (21 days). As well, we evaluate the potential of THC, CBDA, and CBD to reduce anxiogenic responding produced by foot shock (FS) stress 24 h prior to the LD test.
In the absence of the explicit FS stressor, THC (1 and 10 mg/kg) produced anxiogenic-like responding when administered acutely or chronically, but CBDA produced neither anxiogenic- nor anxiolytic-like responding. Administration of FS stress 24 h prior to the LD test enhanced anxiogenic-like responding (reduced time spent and increased latency to enter the light compartment) in rats pretreated with either vehicle (VEH) or THC (1 mg/kg); however, administration of CBDA (0.1–100 μg/kg) or CBD (5 mg/kg) prevented the FS-induced anxiogenic-like responding (an anxiolytic-like effect). The 5-hydroxytryptamine 1A (5-HT1A) receptor antagonist, WAY100635, reversed CBDA’s anxiolytic effect (1 μg/kg). Combining an anxiolytic dose of CBDA (1 μg/kg) or CBD (5 mg/kg) with an anxiogenic dose of THC (1 mg/kg) did not modify THC’s anxiogenic effect.
These results suggest the anxiolytic effects of CBDA and CBD may require the presence of a specific stressor.
KeywordsAnxiety Anxiolytic Δ9-tetrahydrocannabiol Cannabidiolic acid Cannabidiol Foot shock Stress Light-dark emergence test Rat
This work was supported by a Natural Sciences and Engineering Research Council of Canada (NSERC) Collaborative Research and Development Grant (CRDPJ 476416-14) to LAP in partnership with Prairie Plant Systems Inc., as well as a grant to LAP from the NSERC (92056) and from Canadian Institute of Health Research (137122).
Compliance with ethical standards
All animal procedures complied with the Canadian Council on Animal Care and were approved by the Institutional Animal Care Committee (accredited by the Canadian Council on Animal Care).
Conflict of interest
The authors declare that they have no conflict of interest.
- Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F et al (2011) Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Neuropsychopharmacology 36:1219–1226. doi: 10.1038/npp.2011.6 CrossRefPubMedPubMedCentralGoogle Scholar
- Bolognini D, Rock EM, Cluny NL, Cascio MG, Limebeer CL, Duncan M et al (2013) Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation. Br J Pharmacol 168:1456–1470. doi: 10.1111/bph.12043 CrossRefPubMedPubMedCentralGoogle Scholar
- Brierley DI, Samuels J, Duncan M, Whalley BJ, Williams CM (2016) Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea. Psychopharmacology 233:243–254. doi: 10.1007/s00213-015-4100-1 CrossRefPubMedGoogle Scholar
- Fogaça MV, Reis FM, Campos AC, Guimarães FS (2014) Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: involvement of 5HT1A receptors and previous stressful experience. Eur Neuropsychopharmacol 24:410–419. doi: 10.1016/j.euroneuro.2013.10.012 CrossRefPubMedGoogle Scholar
- Gomes FV, Reis DG, Alves FH, Corrêa FM, Guimarães FS, Resstel LB (2012) Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J Psychopharmacol 26:104–113. doi: 10.1177/0269881110389095 CrossRefPubMedGoogle Scholar
- Hindocha C, Freeman TP, Schafer G, Gardener C, Das RK, Morgan CJ et al (2015) Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. Eur Neuropsychopharmacol 25:325–334. doi: 10.1016/j.euroneuro.2014.11.014 CrossRefPubMedPubMedCentralGoogle Scholar
- Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T et al (2011) Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats. Psychopharmacology 218:443–457. doi: 10.1007/s00213-011-2342-0 CrossRefPubMedGoogle Scholar
- Martin-Santos R, Crippa JA, Batalla A, Bhattacharyya S, Atakan Z, Borgwardt S et al (2012) Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers. Curr Pharm Des 18:4966–4979. doi: 10.2174/138161212802884780 CrossRefPubMedGoogle Scholar
- Polissidis A, Chouliara O, Galanopoulos A, Rentesi G, Dosi M, Hyphantis T et al (2010) Individual differences in the effects of cannabinoids on motor activity, dopaminergic activity and DARPP-32 phosphorylation in distinct regions of the brain. Int J Neuropsychopharmacol 13:1175–1191. doi: 10.1017/S1461145709991003 CrossRefPubMedGoogle Scholar
- Resstel LB, Tavares RF, Lisboa SF, Joca SR, Corrêa FM, Guimarães FS (2009) 5-HT1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats. Br J Pharmacol 156:181–188. doi: 10.1111/j.1476-5381.2008.00046.x CrossRefPubMedPubMedCentralGoogle Scholar
- Rock EM, Limebeer CL, Parker LA (2015) Effect of combined doses of Δ(9)-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague-Dawley) models of conditioned gaping. Psychopharmacology 232:4445–4454. doi: 10.1007/s00213-015-4080-1 CrossRefPubMedGoogle Scholar
- Russo EB, Burnett A, Hall B, Parker KK (2005) Agonistic Properties of Cannabidiol at 5-HT1a Receptors. Neurochem Res 30(8):1037–1043Google Scholar
- Todd SM, Zhou C, Clarke DJ, Chohan TW, BAhceci D, Arnold JC (2017) Interactions between cannabidiol and ∆-9 THC following acute and repeated dosing: rebound hyperactivity, sensorimotor gaiting and epigenetic and neuroadaptive changes in the mesolimbic pathway. Eur Neuropsychopharmacol 27:132–145. doi: 10.1016/j.euroneuro.2016.12.004 CrossRefPubMedGoogle Scholar